• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

Vitamins and Dietary Supplements in Belgium

  • ID: 313088
  • June 2015
  • Region: Europe, Belgium
  • 46 Pages
  • Euromonitor International

FEATURED COMPANIES

  • Arkopharma NV SA
  • Biodiphar NV SA
  • Centrapharm NV SA
  • Madaus Pharma NV SA
  • Omega Pharma SA
  • Sanofi-Synthélabo NV
  • MORE

The scenario that was anticipated in vitamins and dietary supplements in 2014 did not really unfold. In December 2012, the regulatory environment for the category became stricter. New regulations regarding health claims from EFSA (European Food Safety Authority) were progressively applied until reaching a point of zero tolerance at the end of 2013. Thus, most manufacturers feared the worst for sales of vitamins and dietary supplements in 2014.

The Vitamins and Dietary Supplements in Belgium report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2010-2014, allowing you to identify the sectors driving growth. Forecasts to 2019 illustrate how the market is set to change.

Product coverage: Dietary Supplements, Paediatric Vitamins and Dietary Supplements, Tonics and Bottled Nutritive Drinks, Vitamins.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
- Get a detailed picture of the Vitamins and Dietary Supplements market;
- Pinpoint growth sectors and identify factors driving change;
- Understand the competitive environment, the market’s major players and leading brands;
- Use five-year forecasts to assess how the market is predicted to develop.

Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Arkopharma NV SA
  • Biodiphar NV SA
  • Centrapharm NV SA
  • Madaus Pharma NV SA
  • Omega Pharma SA
  • Sanofi-Synthélabo NV
  • MORE

VITAMINS AND DIETARY SUPPLEMENTS IN BELGIUM

June 2015

LIST OF CONTENTS AND TABLES

Headlines
Trends
Vitamins
Dietary Supplements
Competitive Landscape
Prospects
Category Data
Summary 1 Dietary Supplements: Brand Ranking by Positioning 2014
Summary 2 Multivitamins: Brand Ranking by Positioning 2014
Table 1 Sales of Vitamins and Dietary Supplements by Category: Value 2009-2014
Table 2 Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2009-2014
Table 3 Sales of Multivitamins by Positioning: % Value 2009-2014
Table 4 Sales of Dietary Supplements by Positioning: % Value 2009-2014
Table 5 NBO Company Shares of Vitamins and Dietary Supplements: % Value 2010-2014
Table 6 LBN Brand Shares of Vitamins and Dietary Supplements: % Value 2011-2014
Table 7 LBN Brand Shares of Vitamins: % Value 2011-2014
Table 8 LBN Brand Shares of Dietary Supplements: % Value 2011-2014
Table 9 Forecast Sales of Vitamins and Dietary Supplements by Category: Value 2014-2019
Table 10 Forecast Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2014-2019
Laboratoria Qualiphar NV SA in Consumer Health (belgium)
Strategic Direction
Key Facts
Summary 3 Laboratoria Qualiphar NV SA: Key Facts
Summary 4 Laboratoria Qualiphar NV SA: Operational Indicators
Company Background and Production
Competitive Positioning
Summary 5 Laboratoria Qualiphar NV SA: Competitive Position 2014
Merck Consumer Healthcare Belgium NV SA in Consumer Health (belgium)
Strategic Direction
Key Facts
Summary 6 Merck Consumer Healthcare Belgium NV SA: Key Facts
Summary 7 Merck Consumer Healthcare Belgium NV SA: Operational Indicators
Company Background and Production
Competitive Positioning
Summary 8 Merck Consumer Healthcare Belgium NV SA: Competitive Position 2014
Omega Pharma Belgium NV in Consumer Health (belgium)
Strategic Direction
Key Facts
Summary 9 Omega Pharma Belgium NV: Key Facts
Summary 10 Omega Pharma Belgium NV: Operational Indicators
Company Background
Production
Summary 11 Omega Pharma Belgium NV: Production Statistics 2014
Competitive Positioning
Summary 12 Omega Pharma Belgium NV: Competitive Position 2014
Upsa Médica NV SA in Consumer Health (belgium)
Strategic Direction
Key Facts
Summary 13 UPSA Médica NV SA: Key Facts
Summary 14 UPSA Médica NV SA: Operational Indicators
Company Background
Production
Summary 15 UPSA Médica NV SA: Production Statistics 2014
Competitive Positioning
Summary 16 UPSA Médica NV SA: Competitive Position 2014
Executive Summary
Market Registers A Decline in 2014 for the First Time in the Review Period
OTC Suffers A Decline While Non-otc Products Do Well
Belgian Operators Fare Much Better Than Multinationals
Distribution Remains Strongly Regulated
Mixed Prospects Overall for Consumer Health
Key Trends and Developments
Weather Impacts Consumer Health More Than the Local Economy
Unexpected Outcome From New European and Local Legislation
Belgian Players Are More Accustomed To Local Constraints
Market Indicators
Table 11 Consumer Expenditure on Health Goods and Medical Services: Value 2009-2014
Table 12 Life Expectancy at Birth 2009-2014
Market Data
Table 13 Sales of Consumer Health by Category: Value 2009-2014
Table 14 Sales of Consumer Health by Category: % Value Growth 2009-2014
Table 15 NBO Company Shares of Consumer Health: % Value 2010-2014
Table 16 LBN Brand Shares of Consumer Health: % Value 2011-2014
Table 17 Penetration of Private Label in Consumer Health by Category: % Value 2009-2014
Table 18 Distribution of Consumer Health by Format: % Value 2009-2014
Table 19 Distribution of Consumer Health by Format and Category: % Value 2014
Table 20 Forecast Sales of Consumer Health by Category: Value 2014-2019
Table 21 Forecast Sales of Consumer Health by Category: % Value Growth 2014-2019
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventive Medicine
Switches
Summary 17 OTC: Switches 2012-2014
Sources
Summary 18 Research Sources

Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Arkopharma NV SA
  • Biodiphar NV SA
  • Centrapharm NV SA
  • Madaus Pharma NV SA
  • Omega Pharma SA
  • Sanofi-Synthélabo NV
  • MORE

Slightly better growth expected
After two years of non-negligible growth, OTC healthcare might perform better up to 2010 than during the historic period thanks to the diminishing effects of government policy, the development of more segmented and convenient products and the ageing population.

Analgesics, cough, cold and allergy remedies, digestive remedies and even medicated skin care will enjoy modest but positive growth despite the expected upsurge of private label products. Deregulated dietary supplements will remain the strongest growth driver thanks to manufacturer creativity in developing products to match the rising demand for preventive treatments and functional substances.

Note: Product cover images may vary from those shown

Companies Mentioned Include:
- Janssen-Cilag NV
- Synthélabo Belgium SA
- Boehringer Ingelheim NV SA
- Novartis Consumer Health SA NV
- Roche NV SA
- Omega Pharma SA
- Procter & Gamble Eurocor NV SA
- Merck Sharp & Dohme BV
- Pfizer Consumer Healthcare NV SA
- Boots Healthcare NV
- Glaxo Wellcome Belgium NV
- UPSA Médica NV SA
- Aventis Pharma NV SA
- Zambon NV SA
- Bayer NV SA
- Beiersdorf NV SA
- Ricola AG
- Menarini Benelux
- Viatris GmbH & Co KG
- Norgine NV SA
- Laboratoria Qualiphar NV SA
- Sanofi-Synthélabo NV
- Biodiphar NV SA
- Centrapharm NV SA
- Will Pharma NV SA
- Bio-Fyt Pharma NV
- Whitehall Benelux SA
- Arkopharma NV SA
- Fournier Pharma NV SA
- Biodynamics NV
- Ortis, Laboratoires
- Madaus Pharma NV SA

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Archer Daniels Midland Company Tate & Lyle, PLC. Comvita Natural Health Ltd. Danisco A/S Kerry Group Groupe Danone